Related Experiment Videos
Postoperative analgesia with Duromorph
Abstract:
The analgesic effects and bioavailability of a slow-release preparation of morphine (Duromorph) were studied in 12 patients with acute postoperative pain. Duromorph produced significant analgesia within 1-2 h of administration i.m., and there was a progressive decrease in the mean pain score for at least 8 h. None of the patients requested or received additional analgesia within 12 h, and the incidence of side-effects was similar to that associated with i.m. morphine. During the 8-h study, plasma concentrations of morphine slowly increased for 3 h, and then gradually declined. After 3 h, concentrations were invariably greater than those produced by conventional doses of morphine sulphate i.m. The study confirmed that Duromorph was an effective analgesic with a prolonged duration of action, which was suitable for the management of postoperative pain.
Insights
Duromorph, a slow-release morphine preparation, effectively managed acute postoperative pain for at least 8 hours. This study found it provided significant pain relief with a prolonged action and comparable side effects to standard morphine injections.
Area of Science:
- Pharmacology
- Pain Management
- Clinical Pharmacy
Background:
- Acute postoperative pain requires effective and sustained analgesia.
- Conventional morphine formulations may necessitate frequent dosing.
- Slow-release formulations offer potential for improved pain control and patient compliance.
Purpose of the Study:
- To evaluate the analgesic efficacy and bioavailability of Duromorph, a slow-release morphine preparation.
- To assess the duration of action and side-effect profile of Duromorph in postoperative pain.
- To compare plasma concentrations of Duromorph with conventional intramuscular morphine sulphate.
Main Methods:
- A study involving 12 patients experiencing acute postoperative pain.
- Administration of Duromorph via intramuscular injection.
- Monitoring of pain scores and assessment of side effects over an 8-hour period.
- Measurement of plasma morphine concentrations over time.
Main Results:
- Duromorph demonstrated significant analgesia within 1-2 hours, with pain scores progressively decreasing for at least 8 hours.
- No patients required additional analgesia within 12 hours post-administration.
- Plasma morphine concentrations increased for 3 hours, remaining elevated compared to conventional doses for up to 8 hours.
- The incidence of side effects was comparable to standard intramuscular morphine.
Conclusions:
- Duromorph is an effective analgesic for acute postoperative pain.
- The slow-release formulation provides a prolonged duration of action, reducing the need for supplemental analgesia.
- Duromorph offers a suitable option for managing postoperative pain, with a favorable pharmacokinetic profile and safety compared to conventional morphine.